Otis W Brawley is of Lyell Immunopharma, Inc.. Currently has a direct ownership of 35,640 shares of LYEL, which is worth approximately $19,245. The most recent transaction as insider was on Mar 31, 2025, when has been sold 35,640 shares (Common Stock) at a price of $0.56 per share, resulting in proceeds of $19,958. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.6K
n/a 3M change
n/a 12M change
Total Value Held $19,245

OTIS W BRAWLEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
BUY
Open market or private purchase
$19,958 $0.56 p/Share
35,640 Added 50.0%
35,640 Common Stock

Also insider at

PDSB
PDS Biotechnology Corp Healthcare
A
AGILENT TECHNOLOGIES, INC. Healthcare
INCY
INCYTE CORP Healthcare
OWB

Otis W Brawley

Santa Clara, CA

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL